Rationale for Use of Amiodarone and Its Derivatives for Treatment of Chagas' Disease and Leishmaniasis.
Rationale for Use of Amiodarone and Its Derivatives for Treatment of Chagas' Disease and Leishmaniasis.
Curr Pharm Des. 2020 Sep 28;:
Authors: Benaim G, Paniz-Mondolfi AE, Sordillo EM
Abstract
The repurposing or repositioning of previously-approved drugs has become an accepted strategy for expansion of the pharmacopeia for neglected diseases. Accordingly, amiodarone, an inexpensive and extensively-used class III antiarrhythmic has been proposed as a treatment for Chagas' disease and leishmaniasis. Amiodarone has a potent trypanocidal and leishmanicidal action, mainly acting through the disruption of parasite intracellular Ca2+ homeostasis, which is a recognized target of different drugs that have activity against trypanosomatids. Amiodarone collapses the mitochondrial electrochemical potential (Δφm) and induces the rapid alkalinization of parasite acidocalcisomes, driving a large increase in the intracellular Ca2+ concentration. Amiodarone also inhibits oxidosqualene cyclase activity, a key enzyme in the ergosterol synthesis pathway that is essential for trypanosomatid survival. In combination, these three effects lead to parasite death. Dronedarone, a drug synthesized with the objective of minimizing some of the adverse effects of amiodarone, displays trypanocidal and leishmanicidal activity through the same mechanisms, but curiously, being more potent on Leishmaniasis than its predecessor. In vitro studies suggest that other rece...
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Benaim G, Paniz-Mondolfi AE, Sordillo EM Tags: Curr Pharm Des Source Type: research
More News: Amiodarone | Chagas Disease | Drugs & Pharmacology | Mitochondrial Disease | Parasitic Diseases | Parasitology | Study